
Dapaflozin 5mg Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Dapagliflozin (5mg)
Overview Dapaflozin 5mg Tablet
Empagliflozin 5mg tablets are prescribed, either independently or alongside other medications, to manage type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to heart health protection. The 5mg tablet may be ingested with or without food, consistently at the same time each day, as determined by your physician. Discontinuing treatment without consulting your doctor may lead to uncontrolled blood sugar, increasing vulnerability to kidney issues and vision impairment. This medication forms part of a comprehensive treatment plan involving a balanced diet, regular physical activity, and weight management under medical supervision. Frequently reported side effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Increased fluid loss is possible; ample hydration is crucial to counteract dehydration. Practicing good hygiene helps prevent genital infections. Prior to commencing treatment, disclose any kidney, liver, or urinary tract problems, diuretic use, or pregnancy/breastfeeding status to your doctor. Limiting alcohol consumption is advised due to the potential for exacerbated side effects. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Dapaflozin 5mg Tablet
No text provided to rephrase.
Uses of Dapaflozin 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dapaflozin 5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaflozin 5mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dapaflozin 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaflozin 5mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. The 5mg Dapaflozin tablet can be administered with or without food, although consistent daily timing is recommended.
How Dapaflozin 5mg Tablet works:
Dapagliflozin 5mg tablets are used to treat diabetes. Their mechanism of action involves the excretion of surplus glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapaflozin 5mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapaflozin 5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of 5mg Dapaflozin tablets are likely incompatible. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Individuals with kidney impairment should not take Dapaflozin 5mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Dapaflozin 5mg tablets without requiring any dosage modification.
What if you forget to take Dapaflozin 5mg Tablet :
Should you forget to take your Dapaflozin 5mg Tablet, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapaflozin 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
